GSK Investigational Site

Newtown 2113

0 studies enrolling now · 3 studies all time

What they study most

Asthma, Pulmonary Disease, Chronic Obstructive, Skin Infections, Bacterial

Studies at this site

• A 24-week Evaluation of GSK573719/Vilanterol (62.5/25mcg) and Components in COPD — Completed
• A Randomized Study To Evaluate The Efficacy And Safety Of An Investigational Drug In Adolescent And Adult Subjects With Persistent Asthma. — Completed
• Pharmacokinetics of Retapamulin in Pediatric Subjects With Uncomplicated Skin Infections. — Completed